secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptiNose, Inc. (—)
CIK:        0001494650
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001104659-25-051326
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 5.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paratek completes $330M acquisition of OptiNose; OptiNose stockholders receive $9/share cash plus CVRs
--------------------------------------------------------------------------------

- All outstanding OptiNose shares converted into $9 cash and one CVR per share (up to $5 additional).
- CVRs pay $1/share if XHANCE net sales ≥$150M in any calendar year by Dec 31, 2028; $4/share if ≥$225M by Dec 31, 2029.
- OptiNose common stock to be delisted from Nasdaq; trading halted pre-open on May 21, 2025.
- Evan Loh becomes sole director and CEO of surviving OptiNose subsidiary; prior board and officers resigned.
- Transaction financed by Paratek, B-FLEXION, Novo Holdings, and Oaktree debt financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494650/000110465925051326/0001104659-25-051326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494650/000110465925051326/tm2515652d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-051326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer